USD 12.4 billion
Report ID:
SQMIG35B2059 |
Region:
Global |
Published Date: October, 2024
Pages:
200
|Tables:
67
|Figures:
75
Animal Vaccines Market size was valued at USD 12.8 Billion in 2023 and is poised to grow from USD 14 Billion in 2024 to USD 28.58 Billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
Increased outbreaks of animal disease and an ever-increasing livestock population are the primary reasons for the wider acceptance of ruminant vaccines, particularly cattle vaccines, around the world. Meat, protein, food, milk, and other commercial products such as wool and leather are all obtained from animals.Rabies vaccines, equine influenza virus vaccines, and foot and mouth disease vaccines are the most commonly used animal vaccines, which prevent the transmission of infectious agents by mimicking naturally immune defense.
Growing concerns about food security, as well as increased animal husbandry, are driving up demand for livestock vaccines. Globally, increased demand for animal products has resulted in increased livestock production. Moreover, various factors such as changing food preferences as a result of changing lifestyles and population growth are driving up demand for livestock products.These factors are assisting the market expansion. The constant introduction of technologically advanced vaccines, as well as the outbreak of livestock diseases, have all contributed to changing market dynamics.
US Animal Vaccines Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 12.4 billion
Largest Segment
Drugs
Fastest Growth
Drugs
Growth Rate
9.60% CAGR
To get more reports on the above market click here to Buy The Report
Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal. Based on Animal Type, the market is segmented into Livestock, and Companion Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Animal Vaccines Market Analysis by Type
In 2021, the attenuated live vaccines segment dominated the animal vaccines market, with a revenue share of over 36.76%. By activating a wide range of immune responses, attenuated vaccines can provide stronger immunity than other vaccines. Furthermore, it helps to reduce the need for booster vaccines that can be given orally and induces long-lasting and rapid immunity, all of which contribute to the growth of the animal vaccines market. In the veterinary field, live attenuation is the oldest vaccination method. This method is also being tested for the creation of new applications. The development of protein subunit vaccines for swine that are administered intramuscularly is one of these alternatives.
Animal Vaccines Market Analysis by Animal Type
In 2021, the livestock segment dominated the market, accounting for more than 70% of total revenue. Factors such as rising livestock populations, supportive government initiatives, and disease outbreaks among cattle and sheep can all be blamed for this. Merck & Co., Inc. has developed vaccines to prevent E. coli, including Aviguard and Nobilis E. coli inac. According to SQ study, Coli prevalence rates in various cattle categories (feedlot cattle, cattle on irrigated pasture, cattle at slaughter, and cattle grazing rangeland forages) range from 0.2% to 27.8%.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the global market, accounting for more than 27.5% of revenue in 2021. Throughout the forecast period, the region is expected to maintain its dominant position. This large proportion can be attributed to the high prevalence of livestock and zoonotic diseases, which result in mass animal deaths. Furthermore, the large presence of well-established pharmaceutical firms that are consistently striving for broad commercialization of their vaccines and expanding their geographic reach is expected to drive market growth. Furthermore, rising incidence of canine disorders, which is increasing the adoption of vaccination for the same, and rising pet population in the United States are some of the key factors contributing to the regional market expansion.
The Asia Pacific region is expected to witness fastest growth in the global animal vaccines market. Pet adoption is on the rise, major vaccination players are expanding, product availability is rising, and manufacturing facilities are being invested in across the Asia Pacific, particularly in India, China, and Thailand, boosting market growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Animal Vaccines Market Driver
Animal Vaccines Market Restraint
● In developing countries of Africa, Asia, and Latin America, it is estimated that there are 600-900 million smallholder farmers who own livestock. Animal vaccination adoption among these smallholder farmers is limited due to a variety of factors, including lack of awareness about the benefits, limited accessibility as they cannot afford the cost of the immunization products and dearth of availability due to a weak supply chain. A significant number of livestock animals owned by smallholder farmers die as a result of various diseases, putting them under additional economic strain. Various strategies are being adopted by governments and agencies to improve the adoption of animal immunization among smallholder farmers by increasing accessibility, availability, and affordability.
Request Free Customization of this report to help us to meet your business objectives.
In terms of the competitive landscape, a few companies have dominated this market due to their strong product portfolios and key strategic decisions. These include 4-5 veterinary vaccine manufacturers with ongoing research and development for new product approvals and a broad geographical presence. The emphasis on inorganic strategies, such as Elanco's acquisition of Bayer's Animal Health division, is expected to further consolidate the major revenue share. With the presence of numerous small and large animal vaccine manufacturers. The rapid adoption of veterinary preventive injections, combined with government-aided bulk purchase of veterinary vaccines, are key factors influencing competition. Furthermore, to maintain market share and diversify product portfolios, major players frequently pursue strategies such as mergers and acquisitions, partnerships, and new product launches.
Top Players in the Global Animal Vaccines Market
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, increased commercial food animal production has resulted from increased demand for animal protein. Emerging zoonotic diseases in companion and livestock animals pose a significant risk to public health. The world will inevitably continue to experience emerging disease outbreaks in the coming decades. Therefore, animal vaccines can play a crucial role in controlling emerging diseases.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 12.4 billion |
Market size value in 2031 | USD 28.30 billion |
Growth Rate | 9.60% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Animal Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Animal Vaccines Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Animal Vaccines Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Animal Vaccines Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35B2059
sales@skyquestt.com
USA +1 351-333-4748